11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management

11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management

Core Knowledge: When major burn trauma creates extensive cutaneous deficits, the availability of healthy donor skin becomes the ultimate rate-limiting factor for survival. Modern burn surgery addresses this challenge through two cutting-edge cellular regenerative paradigms: point-of-care autologous cell suspensions (ReCell) and laboratory-expanded cultured epithelial autografts (CEA). In parallel, optimal management of split-thickness donor sites—often the most excruciatingly painful component of the patient's post-operative recovery—is essential to prevent donor site conversion and facilitate rapid re-harvesting.

---

1. Autologous Cell Harvesting: The ReCell System

The ReCell Autologous Cell Harvesting Device is an FDA-approved, point-of-care cellular regenerative platform that transforms a tiny, ultra-thin split-thickness skin biopsy into an Autologous Cell Suspension (ACS) within the operating room in approximately 30 minutes.

                      RECELL POINT-OF-CARE WORKFLOW
  
  [ Step 1: Biopsy ]        Harvest ultra-thin STSG (0.005–0.008"; ~2x2 cm)
          │
          ▼
  [ Step 2: Incubation ]    Enzymatic digestion in heated trypsin solution (37°C, 15–20 min)
          │                 (Cleaves dermal-epidermal junction)
          ▼
  [ Step 3: Scraping ]      Mechanically scrape basal layer to isolate individual cells
          │
          ▼
  [ Step 4: Suspension ]    Rinse with buffer solution, filter through micro-pore strainer
          │                 (Yields ACS: Keratinocytes, Melanocytes, Fibroblasts)
          ▼
  [ Step 5: Spray Delivery] Aerosolize cell suspension over wound bed / meshed autograft
                            (Expansion ratio up to 1:80; covers up to 320 cm² per 4 cm² biopsy)

Cellular Composition and Biological Mechanisms

Unlike isolated cultured keratinocyte sheets, the ReCell suspension delivers a diverse, multi-phenotypic population of uncultured, disaggregated cells directly from the basal and suprabasal layers of the patient's skin:

• Basal Keratinocytes (Stem Cells): Proliferate rapidly and migrate outward across the wound bed, initiating multi-focal re-epithelialization islands that rapidly merge.
• Melanocytes: Crucial for producing melanin and restoring natural skin pigmentation. Spraying melanocytes dramatically reduces post-burn dyschromia, hypopigmentation, and the "patchwork" cosmetic deformities typical of traditional meshed grafting.
• Dermal Papillary Fibroblasts: Synthesize organized extracellular matrix components, balancing collagen remodeling and reducing hypertrophic scar formation.
• Langerhans Cells: Restore local cutaneous immune surveillance and antigen-presenting defenses in the newly epithelialized wound.

Clinical Applications and Expansion Ratios

• Massive Expansion Ratio: A tiny $2\times 2\text{ cm}$ ($4\text{ cm}^2$) biopsy yields enough cellular suspension to cover up to $320\text{ cm}^2$ of wound area—representing a clinical expansion ratio of up to 1:80.
• Standalone Therapy for Partial-Thickness Burns: In clean superficial-to-deep partial-thickness burns (e.g., pediatric scalds, flash burns), ReCell can be sprayed directly onto debrided wound beds without any sheet autograft, achieving definitive epithelialization within 7 to 10 days with superior cosmetic and scar elasticity outcomes.
• Co-Application Over Widely Meshed Autografts: In extensive full-thickness burns, ReCell is sprayed directly over 1:2, 1:3, or 1:4 meshed autografts. The sprayed cells seed the open interstitial diamond spaces, accelerating interstitial closure from 14–21 days down to 5 to 7 days, smoothing the waffle-mesh pattern, and significantly reducing secondary contracture.

---

2. Cultured Epithelial Autografts (CEA / Epicel)

Cultured Epithelial Autografts (CEA), commercially available as Epicel, represent a specialized laboratory-based tissue engineering salvage therapy reserved exclusively for massive, catastrophic burns ($>70%\text{ TBSA}$) where autograft donor sites are totally exhausted.

                         CEA / EPICEL LIFECYCLE
  
  [ Day 0: Biopsy ]       2–3 full-thickness skin biopsies (2x2 cm) taken from unburned groin/axilla
          │
          ▼
  [ Days 1–21: Culture ]  Dispatched to specialized laboratory; keratinocytes isolated and
                          expanded on irradiated murine 3T3 fibroblast feeder layers
          │
          ▼
  [ Days 16–28: Delivery] 2–8 cell-layer thick confluent epidermal sheets attached to
                          petrolatum gauze backings flown directly to burn center
          │
          ▼
  [ Day 21+: Placement ]  Meticulously stapled to vascularized wound bed / allograft dermis;
                          immobilized for 7–10 days under specialized non-shear dressings

Limitations and Clinical Vulnerabilities of CEA

While life-saving in catastrophic burns, CEA exhibits profound physiological limitations that require highly specialized nursing care:

1. Total Absence of Dermis: CEA consists only of fragile epidermal keratinocytes without an underlying dermal collagen matrix. Without dermis, CEA lacks mechanical tensile strength and tissue compliance.
2. Delayed Anchoring Fibril Formation: The structural anchoring fibrils (Type VII collagen) that secure the epidermal basement membrane to the underlying dermis require several months to a full year to fully develop. Consequently, CEA sheets are exquisitely fragile; the slightest friction or shear force will cause the cultured epidermis to blister and slough off (epidermolysis).
3. Extreme Susceptibility to Microbial Lysis: Bacterial colonization (especially Pseudomonas or Proteus) rapidly digests the delicate single-cell layers, causing total graft loss within hours.
4. High Cost and Long Lead Time: The 2- to 4-week laboratory culturing window requires the patient to be bridged with cryopreserved allograft in the burn ICU while awaiting CEA delivery.
5. Optimal Take on Dermal Scaffolds: To improve survival, CEA is ideally placed over a prepared vascularized allograft dermis (Cuono technique) or Integra neodermis, where the cadaveric epidermis has been stripped away leaving only the vascularized human dermal bed.

Comparative Analysis: ReCell vs. CEA vs. Standard STSG

---

3. Split-Thickness Donor Site Selection & Management

A split-thickness donor site represents an acute, iatrogenic partial-thickness burn wound created by the surgeon's dermatome. Effective donor site management is critical to promote rapid re-epithelialization, prevent infection, control excruciating pain, and enable repeat harvests in extensive burn injuries.

                      DONOR SITE ANATOMICAL HIERARCHY
  
  [ 1. Anterolateral Thighs ] ──► Preferred first-line; large, flat surface, easily dressed
  [ 2. Buttocks / Flanks    ] ──► Excellent thickness; easily concealed cosmetically
  [ 3. Posterior Trunk/Back ] ──► Large surface area; ideal for massive burn harvesting
  [ 4. Abdomen / Upper Arms ] ──► Useful secondary sites; caution around joints
  [ 5. SCALP                ] ──► ELITE SITE IN EXTENSIVE BURNS: Rapid 5–7 day healing,
                                  repeat harvest 4–6 times, zero cosmetic alopecia
  
  [ AVOID / CONTRAINDICATED ] ──► Face, anterior neck, hands, feet, across joint flexures

Anatomical Selection Hierarchy

1. Anterolateral Thighs and Buttocks: The premier first-line donor locations. They offer broad, flat planes for smooth dermatome tracking, adequate dermal thickness, and easy concealment under clothing.
2. Back and Flanks: Ideal for large surface area harvests in major burns. Positioning requires careful post-operative turning protocols to avoid prolonged pressure ischemia.
3. The Scalp as an Elite Donor Site: In extensive, massive burn injuries ($>50%\text{ TBSA}$), the scalp represents an invaluable, highly specialized donor site:
   • Rapid Healing Dynamics: Due to the dense, rich microvascular blood supply of the head and an immense concentration of deep hair follicles (which house robust reservoirs of epithelial stem cells in the follicular bulges), scalp donor sites re-epithelialize extraordinarily fast—typically within 5 to 7 days.
   • Repeat Harvestability: The scalp can be harvested repeatedly 4 to 6 times or more throughout a single hospitalization without compromising healing capacity.
   • Cosmetic Hair Preservation: When harvested at standard thin-to-medium depth (0.008 to 0.010 inches), the deep hair roots (located $3\text{ to }5\text{ mm}$ deep in the subcutaneous fat) remain completely intact, allowing normal hair regrowth with zero permanent alopecia or visible scarring.

Dermatome Harvesting Mechanics and Donor Depth

• Power dermatomes (air or electric) are calibrated precisely between 0.010 and 0.014 inches (0.25 to 0.35 mm) for standard STSG harvesting.
• Mineral oil is applied to the donor skin to reduce friction and allow smooth dermatome gliding.
• The skin is held under taut, uniform two-point tension using wooden tongue depressors or sterile metal guards while the dermatome advances at a steady 45-degree angle.

Neurobiology of Donor Site Pain

Patients universally report that the split-thickness donor site is significantly more painful than the excised, grafted burn wound. The biological rationale is straightforward:

• Full-thickness burns destroy all cutaneous nerve endings, rendering the core burn insensible to light touch.
• In stark contrast, harvesting an STSG transects millions of superficial A-delta and C nociceptive nerve fibers at the mid-dermal level, leaving raw, unmyelinated nerve endings directly exposed to atmospheric air, mechanical friction, and local inflammatory mediators.
• Proactive multimodal pain management—incorporating regional nerve blocks (e.g., Fascia Iliaca Compartment Block for thigh donor sites), scheduled non-opioid analgesics, and moisture-retentive dressings—is mandatory.

---

4. Modern Donor Site Dressing Protocols

Donor site healing relies on the migration and proliferation of keratinocytes from surviving deep hair follicles, sebaceous glands, and sweat gland ducts. Contemporary donor site care prioritizes moisture-retentive environments under a "leave alone" paradigm.

The "Leave-Alone" Nursing Protocol

• Prevent Mechanical Stripping: Never prematurely peel or aggressively pull adherent primary donor site dressings (such as Xeroform, Aquacel Ag, or films). Forcibly removing an adherent dressing rips away newly migrating, single-cell epithelial monolayers, converting a superficial donor site into a deep, scarring wound.
• Spontaneous Separation: As re-epithelialization reaches completion beneath the dressing (typically days 10 to 14), the dressing naturally detaches from the keratinized skin surface. Nurses trim the non-adherent, curled edges daily with sterile scissors until the entire dressing separates cleanly.